Radiation Exposure to Others during I-131 Therapy

Ultima Vez Modificado: 23 de agosto del 2007

Share article


Question

Dear OncoLink "Ask The Experts,"

My mother-in-law received radiation treatments to her thyroid some time ago, and it somehow affected her husband's thyroid function.

Their doctors informed them that their proximity to one another during/after treatment had a ?transferred? effect on him. Is this possible, and if so, for how long?

Answer

Robert Lustig MD FACR, Clinical Associate Professor, Department of Radiation Oncology, University of Pennsylvania, responds:

I assume that your mother in-law was treated with radioactive iodine (I-131). If so, she would then have low levels of radioactivity in her body for a few weeks after therapy. For this reason, people who receive radioactive iodine are typically advised to not have close contact with others, particularly pregnant women or children, for several days after the treatment. Most of the radioactive iodine leaves the body in the first two days through the urine, but there are also small amounts present in sweat, saliva, stool, tears, and vaginal secretions.

Patients undergoing I-131 therapy as outpatients are given instructions to sleep alone for about 5 days, use disposable utensils for meals, launder their clothes and linens separately, bathe daily, and wash hands frequently. The radiation remains in the thyroid for some time, but the levels are greatly diminished within a few days. Patients receiving higher doses of I-131 or those who will not be able to follow the instructions at home are treated in the hospital instead. A radiation safety officer at the hospital monitors all radioactive treatments.

While it is possible that your father in-law did get some exposure, it would be very unlikely that he received enough to actually damage his thyroid. However, if it did damage the thyroid gland, it is most likely permanent and he would require medication to provide him with supplemental thyroid hormone.


News
Beta-Carotene Safe During Prostate Cancer Treatment

Jun 8, 2012 - The use of the antioxidant beta-carotene during radiation therapy treatment for prostate cancer is not associated with an increase in prostate cancer deaths or metastases, according to research published in the May issue of the International Journal of Radiation Oncology*Biology*Physics.



I Wish You Knew

Understanding prostate cancer screening

View More



Blogs and Web Chats

OncoLink Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.




OncoLink OncoPilot

Frente a un nuevo diagnóstico de cáncer o de cambiar el curso de su tratamiento actual? Deje que nuestro personal de enfermería cáncer que ayudan a pasar!

Más información